 Subjects who have a history of human immunodeficiency virus HIV infection or subjects who have an active hepatitis B virus HBV or hepatitis C virus HCV infection requiring treatment due to a theoretical concern that the degree of immune suppression associated with the treatment may result in progression of HIV infection. Subjects with chronic HBV or HCV infection are eligible at the investigator s discretion if the subject is considered non-infectious based on serological markers. 